Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma

Canadian Myeloma Research Group · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
multiple-myelomarelapse
multiple myeloma in relapse, multiple myeloma, relapse, refractory, daratumumab, accelerated infusion, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 911843
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.